Abiopharma

🔍 Garfield Mark S. (Executive)

Company: Workday, Inc. (WDAY)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Acquired 23,277 shares of Class A Common Stock (Direct)
  Date: 2026-05-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 54,744.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 23,277 shares of Class A Common Stock (Direct)
  Date: 2026-05-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 78,021.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Includes 48,751 restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, including 23,277 RSUs with a grant date of May 5, 2026, which will vest as to 1/16 of the underlying shares on July 5, 2026, and then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates.
• F2: Includes 72,028 RSUs, each of which entitle the Reporting Person to receive one share of Class A Common Stock upon settlement, including 23,277 RSUs with a grant date of May 5, 2026, which will vest as to 1/12 of the underlying shares on July 5, 2026, and then quarterly thereafter. All grants are subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates.